Literature DB >> 14557498

Multisection CT evaluation of the reoperative cardiac surgery patient.

Robert C Gilkeson1, Alan H Markowitz, Leslie Ciancibello.   

Abstract

Development of electrocardiographically (ECG) gated multisection computed tomography (CT) has had a significant, immediate impact in cardiovascular imaging. The capabilities of this new technique have become particularly important in the preoperative assessment of the cardiac surgery patient. Cardiac surgery in the 21st century has become increasingly complex because of an aging population needing multiple procedures. As patients live longer, reoperative surgery is often needed, requiring further complicated intervention. Recent research in cardiac surgery patients has linked atherosclerotic disease of the aorta to the risk of perioperative stroke. Multisection CT has been effective in evaluations of the atherosclerotic aorta, minimizing perioperative stroke risk in these often elderly patients. By using the capabilities of ECG gating, improved CT imaging of the aortic valve has helped guide the surgeon in decisions of aortic valve replacement. Injury to preexisting coronary artery grafts is associated with significant perioperative morbidity and mortality. The superior imaging features of ECG-gated CT have enabled preoperative identification of coronary grafts, preventing injury to these important structures during reoperative surgery. Assessment of normal anatomic structures is also important in preoperative planning. Proximity of the aorta, pulmonary artery, and native coronary arteries to the sternum is an important potential cause of morbidity and mortality, and it can be preoperatively assessed with multisection CT. The advancement of ECG gating has enabled accurate assessment of the coronary arteries, which is particularly important in the preoperative identification of congenital and acquired abnormalities. With continued advances, ECG-gated multisection CT will play an increasingly important role in the evaluation of patients with cardiovascular disease. Copyright RSNA, 2003

Entities:  

Mesh:

Year:  2003        PMID: 14557498     DOI: 10.1148/rg.23si035505

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  7 in total

Review 1.  Multidetector CT and coronary artery bypass grafts.

Authors:  F Crusco; A Antoniella; V Papa; D Di Lazzaro; T Ragni; A Giovagnoni
Journal:  Radiol Med       Date:  2007-12-13       Impact factor: 3.469

Review 2.  MDCT prior to median re-sternotomy in cardiovascular surgery: our experiences, infrequent findings and the crucial role of radiological report.

Authors:  Tullio Valente; Giorgio Bocchini; Giovanni Rossi; Giacomo Sica; Hannah Davison; Mariano Scaglione
Journal:  Br J Radiol       Date:  2019-06-20       Impact factor: 3.039

3.  The benefit of 64-MDCT prior to invasive coronary angiography in symptomatic post-CABG patients.

Authors:  R Dikkers; T P Willems; R A Tio; R L Anthonio; F Zijlstra; M Oudkerk
Journal:  Int J Cardiovasc Imaging       Date:  2006-11-04       Impact factor: 2.316

4.  The role of computed tomography in pre-procedural planning of cardiovascular surgery and intervention.

Authors:  Prabhakar Rajiah; Paul Schoenhagen
Journal:  Insights Imaging       Date:  2013-08-02

Review 5.  Korean guidelines for the appropriate use of cardiac CT.

Authors:  Young Jin Kim; Hwan Seok Yong; Sung Mok Kim; Jeong A Kim; Dong Hyun Yang; Yoo Jin Hong
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

6.  The routine use of preoperative non-contrast chest computerized tomography and carotid arteries Doppler prior to cardiac surgery.

Authors:  Ron Nates; Mattan Arazi; Liza Grosman-Rimon; Roy Israel; Jacob Gohari; Leonid Sternik; Erez Kachel
Journal:  J Cardiothorac Surg       Date:  2022-07-23       Impact factor: 1.522

7.  Assessment of thoracic aorta in different cardiac phases in patients with non-aorta diseases using cardiac CT.

Authors:  Xue Zheng; Yu-Jiao Deng; Fu-Gang Han; Jin-Rong Zhou; Li Luo; Jing Chen
Journal:  Sci Rep       Date:  2021-07-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.